Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pieris Pharmaceuticals (PIRS)
NASDAQ:PIRS
Pieris Pharmaceuticals (PIRS) Financial Statements
575 Followers
Pieris Pharmaceuticals Financial Overview
| Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 19.52M | $ 21.67M | $ 2.01M | $ 5.85M | $ 5.37M |
| Gross Profit | $ 19.52M | $ 21.67M | $ 1.94M | $ 5.85M | - |
| EBIT | $ -10.75M | $ 3.98M | $ 19.68M | $ -3.67M | $ -10.70M |
| EBITDA | $ -10.01M | $ 4.73M | $ 20.29M | $ -3.10M | $ -9.93M |
| Net Income Common Stockholders | $ -10.75M | $ 3.98M | $ 19.68M | $ -8.10M | $ -9.74M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 44.81M | $ 54.88M | $ 48.38M | $ 59.17M | $ 69.82M |
| Total Assets | $ 59.38M | $ 87.54M | $ 82.26M | $ 95.49M | $ 99.16M |
| Total Debt | $ 12.29M | $ 11.92M | $ 12.20M | $ 12.24M | $ 12.22M |
| Net Debt | $ -32.52M | $ -42.96M | $ -36.18M | $ -46.92M | $ -57.61M |
| Total Liabilities | $ 28.87M | $ 47.05M | $ 66.80M | $ 67.56M | $ 63.40M |
| Stockholders Equity | $ 30.51M | $ 40.50M | $ 15.46M | $ 27.93M | $ 35.77M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -9.79M | $ -13.50M | $ -11.04M | $ -12.92M | $ -8.81M |
| Operating Cash Flow | $ -9.72M | $ -13.43M | $ -11.00M | $ -12.93M | $ -8.78M |
| Investing Cash Flow | $ -1.98M | $ -1.37M | $ 11.90M | $ 1.11M | $ 5.47M |
| Financing Cash Flow | - | $ 19.78M | - | $ 93.00K | $ 282.00K |
Pieris Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.